Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists. Read more about Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists.
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7). Read more about 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).
Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancer. Read more about Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancer.
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer. Read more about Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer.
Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3. Read more about Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3.
Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer. Read more about Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer.
The role of percutaneous vertebral augmentation in patients with metastatic breast cancer: Literature review including report of two cases. Read more about The role of percutaneous vertebral augmentation in patients with metastatic breast cancer: Literature review including report of two cases.
A multidisciplinary approach to optimizing care of patients treated with alpelisib. Read more about A multidisciplinary approach to optimizing care of patients treated with alpelisib.
Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial. Read more about Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial.
Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability. Read more about Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
